spacer
home > ict > autumn 2016 > communication is key
PUBLICATIONS
International Clinical Trials

Communication is Key

ICT: This year’s spotlight at the Partnerships in Clinical Trials (PCT) Europe event is on patient centricity. In your opinion, what are the main challenges in recruiting and retaining subjects today, and what can be done to improve this often labour-intensive and costly task?

Naomi Brooker: While researching with industry professionals, it appears that one of the fundamental issues lies within how we are communicating – patients don’t want to feel like guinea pigs that are being experimented on. The general public perception is that clinical trials can be risky, and this can be off-putting; after all, they generally only see the disasters in the news, not the many success stories that arise from trials. In particular, some patients worry that they could be given a placebo that could be detrimental to their health, while others are concerned that companies are more interested in profit than helping them recover; others decided that the risk factor was too great.

To remove this underlying fear, communication is key and marketing campaigns, as well as patient advocates, can play a pivotal role. What are you, as a company, doing to ensure that patients feel valued? How are they engaged with? Are they treated as a number or a person? These are the real questions that can make a difference.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Naomi Brooker is the Conference Director of PCT Europe, developing the event in partnership with their advisory board. Since completing a BSc at UCL, UK, in Biomedical Science and a Law Conversion at BBP Law School, UK, she has been researching key trends and current challenges with various industry sectors such as pharma and agrochemical, most recently focusing on clinical trials.
spacer
Naomi Brooker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

White Papers

The Impact of Components on Drug Quality and Risk Mitigation

West Pharmaceutical Services, Inc.

Expectations for quality by regulatory agencies are increasing at a very fast pace, especially for prefilled drug delivery formats, thanks to increased focus on reducing risk to patient safety. The trend has resulted in delays for new drug applications, more recalls of marketed products and even drug shortages if the container system and drug contents are suspect for quality issues. The pharmaceutical market is now requiring manufacturers of containers and components to meet new expectations with a quality culture and very high product reliability. The need to bridge the gap and provide superior quality products has been a driver for manufacturing technology investments, more robust control strategies and the introduction of next generation elastomer components.
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement